共 50 条
- [23] First line therapy for locally advanced or metastatic urothelial cancer: A randomized double blind phase III multicenter study on adjuvant nivolumab therapy versus placebo in patients with invasive high-risk urothelial cancer (CheckMate 274)—AB 58/17 of the AUO Der Urologe, 2017, 56 (10): : 1331 - 1332
- [24] Trial in progress: A phase II switch maintenance study of live biotherapeutic MRx0518 and avelumab in patients with unresectable locally advanced or metastatic urothelial carcinoma (UC) who did not progress on first-line platinum-containing chemotherapy JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
- [25] Meet-URO 12: A randomized phase II trial of niraparib versus best supportive care (BSC) as maintenance treatment in patients with locally advanced or metastatic urothelial cancer (UC) whose disease did not progress after completion of first-line platinum-based chemotherapy ANNALS OF ONCOLOGY, 2020, 31 : S607 - S607